CIK 0001553643 · Non-accelerated filer<br>Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 455401931
- Phone
- 646 876 3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-30 | TRAVERSA SERGIO Chief Executive Officer | Option exercise | +16,012 | $16.00 | $256K | 104,786 |
| 2022-06-30 | TRAVERSA SERGIO Chief Executive Officer | Sale | −5,314 | $19.37 | $103K | 99,472 |
| 2022-06-30 | TRAVERSA SERGIO Chief Executive Officer | Sale | −10,698 | $19.01 | $203K | 88,774 |
| 2022-06-30 | TRAVERSA SERGIO Chief Executive Officer | Option exercise · Stock Option (right to buy) | −16,012 | 13,755 | ||
| 2022-05-25 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Stock Option (right to buy) | +651,821 | 1,143,994 | ||
| 2022-05-25 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2022-05-25 | Kelly Paul Edward Director | Grant or award · Stock Option (right to buy) | +182,470 | 300,000 | ||
| 2022-05-25 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +295,211 | 522,729 | ||
| 2022-05-25 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-05-25 | GLASSPOOL JOHN Director | Grant or award · Stock Option (right to buy) | +91,235 | 150,000 | ||
| 2022-05-25 | SCHMIDT ERIC THOMAS Director | Grant or award · Stock Option (right to buy) | +91,235 | 150,000 | ||
| 2022-05-25 | Ence Chuck CA and Compliance Officer | Grant or award · Stock Option (right to buy) | +295,404 | 522,236 | ||
| 2022-05-25 | Ence Chuck CA and Compliance Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-05-25 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (right to buy) | +91,235 | 150,000 | ||
| 2022-04-04 | Kelly Paul Edward Director | Option exercise | +10,000 | $3.24 | $32K | 197,295 |
| 2022-04-04 | Kelly Paul Edward Director | Sale | −10,000 | $30.04 | $300K | 187,295 |
| 2022-04-04 | Kelly Paul Edward Director | Option exercise · Options to purchase common stock | −10,000 | 20,500 | ||
| 2022-04-01 | CASAMENTO CHARLES J Director | Option exercise | +19,800 | $3.24 | $64K | 19,800 |
| 2022-04-01 | CASAMENTO CHARLES J Director | Sale | −3,300 | $29.00 | $96K | 16,500 |
| 2022-04-01 | CASAMENTO CHARLES J Director | Sale | −3,300 | $29.00 | $96K | 13,200 |
Page 6 of 9 · 178 trades